Clinical trial Recruiting at 1 site Interventional Ages 45 and up

Continuous wearable vital-sign monitoring versus routine spot-checks after non-cardiac surgery

Official title: The Effect of Continuous Monitoring Versus Routine Spot-checks on Altered Vital Signs in Patients Recovering From Non-cardiac Surgery on Normal Wards: the "COME ON, NOW!" Trial

Run by Universitätsklinikum Hamburg-Eppendorf · NCT07385092 · Data updated 2026-11-12

This trial will test whether continuous wearable vital-sign monitoring can reduce the time abnormal signs go unnoticed in adults recovering on regular wards after major non-cardiac surgery.

More Cardiac Surgery trials

Quick facts

Study typeInterventional
Ages45 Years and up
SexAll
Enrollment264 (estimated)
SponsorUniversitätsklinikum Hamburg-Eppendorf
Academic / other
Locations1 site (Hamburg, Free and Hanseatic City of Hamburg)
StatusRecruiting
StartedFebruary 24, 2026
Main results expectedNovember 1, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 2, 2026
Trial IDNCT07385092 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 45 years or older scheduled for elective major non-cardiac (abdominal or thoracic) surgery with planned postoperative admission to a normal ward are the intended candidates.

Probably not a fit

Patients undergoing emergency surgery, pregnant patients, those with atrial fibrillation, those who cannot be monitored with the Radius VSM sensor, or patients designated DNR/receiving end-of-life care are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, single-center trial in adults recovering from major elective non-cardiac (abdominal or thoracic) surgery who are admitted to a normal ward after an initial post-anesthesia stay. Participants are randomized to different implementations of continuous monitoring using a wearable, wireless sensor system (Radius VSM), with monitoring either visible or blinded to ward staff. The primary outcome is the total duration of abnormal vital signs per hour during the first 48 hours after admission to the normal ward. The goal is to determine whether continuous wearable monitoring shortens the time physiologic instability is present and undetected compared with current intermittent checks.

Why it matters

Potential benefit: If successful, continuous monitoring could allow earlier recognition of deterioration and reduce the time abnormal vital signs go unrecognized, potentially preventing complications.

How similar studies have gone: Previous studies of continuous ward monitoring have shown feasibility and earlier detection of physiologic changes, but randomized evidence that this consistently reduces major complications or mortality remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Consenting patients ≥45 years scheduled for elective non-cardiac (abdominal and thoracic) surgery with planned postoperative admission to a normal ward after an overnight stay in an advanced post-anesthesia care unit.

Exclusion Criteria:

* Emergency surgery
* Pregnancy
* Impossibility to perform continuous monitoring with the Radius VSM sensor (Masimo, Irvine, CA)
* Atrial fibrillation
* Patients designated Do Not Resuscitate, or are receiving end-of-life care

Where it's running

  • University Medical Center Hamburg-Eppendorf
    Hamburg, Free and Hanseatic City of Hamburg, Germany
    Recruiting

Study contacts

  • Principal investigator: Bernd Saugel, MD — Universitätsklinikum Hamburg-Eppendorf
  • Study coordinator: Kristen K Thomsen, MD
  • Email: kr.thomsen@uke.de
  • Phone: +4940741070215

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.